急性骨髄性白血病治療の世界市場 2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global Acute Myeloid Leukemia Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：D0804-14631 • 出版社/出版日：GlobalInfoResearch / 2020年7月21日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、105ページ • 納品方法：Eメール • 産業分類：医療

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、急性骨髄性白血病治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。急性骨髄性白血病治療の種類別市場規模（DCレジメン、AVDレジメン、VCDレジメン）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Ambit Biosciences Corporation、Clavis Pharma、Celgene Corporation、Sunesis Pharmaceuticals、Cephalon、Genzyme Corporation、Eisai ・地域別グローバル市場分析 2015年-2020年 ・急性骨髄性白血病治療の北米市場（アメリカ、カナダ、メキシコ） ・急性骨髄性白血病治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・急性骨髄性白血病治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・急性骨髄性白血病治療の南米市場（ブラジル、アルゼンチン） ・急性骨髄性白血病治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：DCレジメン、AVDレジメン、VCDレジメン ・用途別分析：病院、クリニック、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論

Market Overview
The global Acute Myeloid Leukemia Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 7.6% in the forecast period of 2020 to 2025 and will expected to reach USD 774.8 million by 2025, from USD 578.1 million in 2019.

The Acute Myeloid Leukemia Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Acute Myeloid Leukemia Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Acute Myeloid Leukemia Treatment market has been segmented into:
DC regimen
AVD Regimen
VCD regimen

By Application, Acute Myeloid Leukemia Treatment has been segmented into:
Hospital
Clinic
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Acute Myeloid Leukemia Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Acute Myeloid Leukemia Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Acute Myeloid Leukemia Treatment market.

The report offers in-depth assessment of the growth and other aspects of the Acute Myeloid Leukemia Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Acute Myeloid Leukemia Treatment Market Share Analysis
Acute Myeloid Leukemia Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Acute Myeloid Leukemia Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Acute Myeloid Leukemia Treatment sales, revenue and market share for each player covered in this report.

The major players covered in Acute Myeloid Leukemia Treatment are:
Ambit Biosciences Corporation
Clavis Pharma
Celgene Corporation
Sunesis Pharmaceuticals
Cephalon
Genzyme Corporation
Eisai

レポート目次

---

Table of Contents

1 Acute Myeloid Leukemia Treatment Market Overview
1.1 Product Overview and Scope of Acute Myeloid Leukemia Treatment
1.2 Classification of Acute Myeloid Leukemia Treatment by Type
1.2.1 Global Acute Myeloid Leukemia Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Acute Myeloid Leukemia Treatment Revenue Market Share by Type in 2019
1.2.3 DC regimen
1.2.4 AVD Regimen
1.2.5 VCD regimen
1.3 Global Acute Myeloid Leukemia Treatment Market by Application
1.3.1 Overview: Global Acute Myeloid Leukemia Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Acute Myeloid Leukemia Treatment Market by Regions
1.4.1 Global Acute Myeloid Leukemia Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Acute Myeloid Leukemia Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Acute Myeloid Leukemia Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Acute Myeloid Leukemia Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Acute Myeloid Leukemia Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Acute Myeloid Leukemia Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Acute Myeloid Leukemia Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 Ambit Biosciences Corporation
2.1.1 Ambit Biosciences Corporation Details
2.1.2 Ambit Biosciences Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Ambit Biosciences Corporation SWOT Analysis
2.1.4 Ambit Biosciences Corporation Product and Services
2.1.5 Ambit Biosciences Corporation Acute Myeloid Leukemia Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Clavis Pharma
2.2.1 Clavis Pharma Details
2.2.2 Clavis Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Clavis Pharma SWOT Analysis
2.2.4 Clavis Pharma Product and Services
2.2.5 Clavis Pharma Acute Myeloid Leukemia Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Celgene Corporation
2.3.1 Celgene Corporation Details
2.3.2 Celgene Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Celgene Corporation SWOT Analysis
2.3.4 Celgene Corporation Product and Services
2.3.5 Celgene Corporation Acute Myeloid Leukemia Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Sunesis Pharmaceuticals
2.4.1 Sunesis Pharmaceuticals Details
2.4.2 Sunesis Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Sunesis Pharmaceuticals SWOT Analysis
2.4.4 Sunesis Pharmaceuticals Product and Services
2.4.5 Sunesis Pharmaceuticals Acute Myeloid Leukemia Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Cephalon
2.5.1 Cephalon Details
2.5.2 Cephalon Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Cephalon SWOT Analysis
2.5.4 Cephalon Product and Services
2.5.5 Cephalon Acute Myeloid Leukemia Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Genzyme Corporation
2.6.1 Genzyme Corporation Details
2.6.2 Genzyme Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Genzyme Corporation SWOT Analysis
2.6.4 Genzyme Corporation Product and Services
2.6.5 Genzyme Corporation Acute Myeloid Leukemia Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 Eisai
2.7.1 Eisai Details
2.7.2 Eisai Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Eisai SWOT Analysis
2.7.4 Eisai Product and Services
2.7.5 Eisai Acute Myeloid Leukemia Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Acute Myeloid Leukemia Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Acute Myeloid Leukemia Treatment Players Market Share
3.2.2 Top 10 Acute Myeloid Leukemia Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Acute Myeloid Leukemia Treatment Revenue and Market Share by Regions
4.2 North America Acute Myeloid Leukemia Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Acute Myeloid Leukemia Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Acute Myeloid Leukemia Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Acute Myeloid Leukemia Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Acute Myeloid Leukemia Treatment Revenue and Growth Rate (2015-2020)
5 North America Acute Myeloid Leukemia Treatment Revenue by Countries
5.1 North America Acute Myeloid Leukemia Treatment Revenue by Countries (2015-2020)
5.2 USA Acute Myeloid Leukemia Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Acute Myeloid Leukemia Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Acute Myeloid Leukemia Treatment Revenue and Growth Rate (2015-2020)
6 Europe Acute Myeloid Leukemia Treatment Revenue by Countries
6.1 Europe Acute Myeloid Leukemia Treatment Revenue by Countries (2015-2020)
6.2 Germany Acute Myeloid Leukemia Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Acute Myeloid Leukemia Treatment Revenue and Growth Rate (2015-2020)
6.4 France Acute Myeloid Leukemia Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Acute Myeloid Leukemia Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Acute Myeloid Leukemia Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Acute Myeloid Leukemia Treatment Revenue by Countries
7.1 Asia-Pacific Acute Myeloid Leukemia Treatment Revenue by Countries (2015-2020)
7.2 China Acute Myeloid Leukemia Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Acute Myeloid Leukemia Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Acute Myeloid Leukemia Treatment Revenue and Growth Rate (2015-2020)
7.5 India Acute Myeloid Leukemia Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Acute Myeloid Leukemia Treatment Revenue and Growth Rate (2015-2020)
8 South America Acute Myeloid Leukemia Treatment Revenue by Countries
8.1 South America Acute Myeloid Leukemia Treatment Revenue by Countries (2015-2020)
8.2 Brazil Acute Myeloid Leukemia Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Acute Myeloid Leukemia Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Acute Myeloid Leukemia Treatment by Countries
9.1 Middle East & Africa Acute Myeloid Leukemia Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Acute Myeloid Leukemia Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Acute Myeloid Leukemia Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Acute Myeloid Leukemia Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Acute Myeloid Leukemia Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Acute Myeloid Leukemia Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Acute Myeloid Leukemia Treatment Market Forecast by Type (2019-2024)
10.3 DC regimen Revenue Growth Rate (2015-2025)
10.4 AVD Regimen Revenue Growth Rate (2015-2025)
10.5 VCD regimen Revenue Growth Rate (2015-2025)
11 Global Acute Myeloid Leukemia Treatment Market Segment by Application
11.1 Global Acute Myeloid Leukemia Treatment Revenue Market Share by Application (2015-2020)
11.2 Acute Myeloid Leukemia Treatment Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Clinic Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Acute Myeloid Leukemia Treatment Market Size Forecast (2021-2025)
12.1 Global Acute Myeloid Leukemia Treatment Market Size Forecast (2021-2025)
12.2 Global Acute Myeloid Leukemia Treatment Market Forecast by Regions (2021-2025)
12.3 North America Acute Myeloid Leukemia Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Acute Myeloid Leukemia Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Acute Myeloid Leukemia Treatment Revenue Market Forecast (2021-2025)
12.6 South America Acute Myeloid Leukemia Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Acute Myeloid Leukemia Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Acute Myeloid Leukemia Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Acute Myeloid Leukemia Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Acute Myeloid Leukemia Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Acute Myeloid Leukemia Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Ambit Biosciences Corporation Corporate Information, Location and Competitors
Table 6. Ambit Biosciences Corporation Acute Myeloid Leukemia Treatment Major Business
Table 7. Ambit Biosciences Corporation Acute Myeloid Leukemia Treatment Total Revenue (USD Million) (2017-2018)
Table 8. Ambit Biosciences Corporation SWOT Analysis
Table 9. Ambit Biosciences Corporation Acute Myeloid Leukemia Treatment Product and Solutions
Table 10. Ambit Biosciences Corporation Acute Myeloid Leukemia Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Clavis Pharma Corporate Information, Location and Competitors
Table 12. Clavis Pharma Acute Myeloid Leukemia Treatment Major Business
Table 13. Clavis Pharma Acute Myeloid Leukemia Treatment Total Revenue (USD Million) (2018-2019)
Table 14. Clavis Pharma SWOT Analysis
Table 15. Clavis Pharma Acute Myeloid Leukemia Treatment Product and Solutions
Table 16. Clavis Pharma Acute Myeloid Leukemia Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Celgene Corporation Corporate Information, Location and Competitors
Table 18. Celgene Corporation Acute Myeloid Leukemia Treatment Major Business
Table 19. Celgene Corporation Acute Myeloid Leukemia Treatment Total Revenue (USD Million) (2017-2018)
Table 20. Celgene Corporation SWOT Analysis
Table 21. Celgene Corporation Acute Myeloid Leukemia Treatment Product and Solutions
Table 22. Celgene Corporation Acute Myeloid Leukemia Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Sunesis Pharmaceuticals Corporate Information, Location and Competitors
Table 24. Sunesis Pharmaceuticals Acute Myeloid Leukemia Treatment Major Business
Table 25. Sunesis Pharmaceuticals Acute Myeloid Leukemia Treatment Total Revenue (USD Million) (2017-2018)
Table 26. Sunesis Pharmaceuticals SWOT Analysis
Table 27. Sunesis Pharmaceuticals Acute Myeloid Leukemia Treatment Product and Solutions
Table 28. Sunesis Pharmaceuticals Acute Myeloid Leukemia Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Cephalon Corporate Information, Location and Competitors
Table 30. Cephalon Acute Myeloid Leukemia Treatment Major Business
Table 31. Cephalon Acute Myeloid Leukemia Treatment Total Revenue (USD Million) (2017-2018)
Table 32. Cephalon SWOT Analysis
Table 33. Cephalon Acute Myeloid Leukemia Treatment Product and Solutions
Table 34. Cephalon Acute Myeloid Leukemia Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Genzyme Corporation Corporate Information, Location and Competitors
Table 36. Genzyme Corporation Acute Myeloid Leukemia Treatment Major Business
Table 37. Genzyme Corporation Acute Myeloid Leukemia Treatment Total Revenue (USD Million) (2017-2018)
Table 38. Genzyme Corporation SWOT Analysis
Table 39. Genzyme Corporation Acute Myeloid Leukemia Treatment Product and Solutions
Table 40. Genzyme Corporation Acute Myeloid Leukemia Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Eisai Corporate Information, Location and Competitors
Table 42. Eisai Acute Myeloid Leukemia Treatment Major Business
Table 43. Eisai Acute Myeloid Leukemia Treatment Total Revenue (USD Million) (2017-2018)
Table 44. Eisai SWOT Analysis
Table 45. Eisai Acute Myeloid Leukemia Treatment Product and Solutions
Table 46. Eisai Acute Myeloid Leukemia Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Global Acute Myeloid Leukemia Treatment Revenue (Million USD) by Players (2015-2020)
Table 48. Global Acute Myeloid Leukemia Treatment Revenue Share by Players (2015-2020)
Table 49. Global Acute Myeloid Leukemia Treatment Revenue (Million USD) by Regions (2015-2020)
Table 50. Global Acute Myeloid Leukemia Treatment Revenue Market Share by Regions (2015-2020)
Table 51. North America Acute Myeloid Leukemia Treatment Revenue by Countries (2015-2020)
Table 52. North America Acute Myeloid Leukemia Treatment Revenue Market Share by Countries (2015-2020)
Table 53. Europe Acute Myeloid Leukemia Treatment Revenue (Million USD) by Countries (2015-2020)
Table 54. Asia-Pacific Acute Myeloid Leukemia Treatment Revenue (Million USD) by Countries (2015-2020)
Table 55. South America Acute Myeloid Leukemia Treatment Revenue by Countries (2015-2020)
Table 56. South America Acute Myeloid Leukemia Treatment Revenue Market Share by Countries (2015-2020)
Table 57. Middle East and Africa Acute Myeloid Leukemia Treatment Revenue (Million USD) by Countries (2015-2020)
Table 58. Middle East and Africa Acute Myeloid Leukemia Treatment Revenue Market Share by Countries (2015-2020)
Table 59. Global Acute Myeloid Leukemia Treatment Revenue (Million USD) by Type (2015-2020)
Table 60. Global Acute Myeloid Leukemia Treatment Revenue Share by Type (2015-2020)
Table 61. Global Acute Myeloid Leukemia Treatment Revenue Forecast by Type (2021-2025)
Table 62. Global Acute Myeloid Leukemia Treatment Revenue by Application (2015-2020)
Table 63. Global Acute Myeloid Leukemia Treatment Revenue Share by Application (2015-2020)
Table 64. Global Acute Myeloid Leukemia Treatment Revenue Forecast by Application (2021-2025)
Table 65. Global Acute Myeloid Leukemia Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Acute Myeloid Leukemia Treatment Picture
Figure 2. Global Acute Myeloid Leukemia Treatment Revenue Market Share by Type in 2019
Figure 3. DC regimen Picture
Figure 4. AVD Regimen Picture
Figure 5. VCD regimen Picture
Figure 6. Acute Myeloid Leukemia Treatment Revenue Market Share by Application in 2019
Figure 7. Hospital Picture
Figure 8. Clinic Picture
Figure 9. Others Picture
Figure 10. Global Acute Myeloid Leukemia Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Acute Myeloid Leukemia Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Acute Myeloid Leukemia Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Acute Myeloid Leukemia Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Acute Myeloid Leukemia Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Acute Myeloid Leukemia Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Acute Myeloid Leukemia Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Acute Myeloid Leukemia Treatment Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Acute Myeloid Leukemia Treatment Revenue Market Share in 2019
Figure 19. Global Top 10 Players Acute Myeloid Leukemia Treatment Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Acute Myeloid Leukemia Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Acute Myeloid Leukemia Treatment Revenue Market Share by Regions (2015-2020)
Figure 23. Global Acute Myeloid Leukemia Treatment Revenue Market Share by Regions in 2018
Figure 24. North America Acute Myeloid Leukemia Treatment Revenue and Growth Rate (2015-2020)
Figure 25. Europe Acute Myeloid Leukemia Treatment Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Acute Myeloid Leukemia Treatment Revenue and Growth Rate (2015-2020)
Figure 27. South America Acute Myeloid Leukemia Treatment Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Acute Myeloid Leukemia Treatment Revenue and Growth Rate (2015-2020)
Figure 29. North America Acute Myeloid Leukemia Treatment Revenue Market Share by Countries (2015-2020)
Figure 30. North America Acute Myeloid Leukemia Treatment Revenue Market Share by Countries in 2019
Figure 31. USA Acute Myeloid Leukemia Treatment Revenue and Growth Rate (2015-2020)
Figure 32. Canada Acute Myeloid Leukemia Treatment Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Acute Myeloid Leukemia Treatment Revenue and Growth Rate (2015-2020)
Figure 34. Europe Acute Myeloid Leukemia Treatment Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Acute Myeloid Leukemia Treatment Revenue Market Share by Countries in 2019
Figure 36. Germany Acute Myeloid Leukemia Treatment Revenue and Growth Rate (2015-2020)
Figure 37. UK Acute Myeloid Leukemia Treatment Revenue and Growth Rate (2015-2020)
Figure 38. France Acute Myeloid Leukemia Treatment Revenue and Growth Rate (2015-2020)
Figure 39. Russia Acute Myeloid Leukemia Treatment Revenue and Growth Rate (2015-2020)
Figure 40. Italy Acute Myeloid Leukemia Treatment Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Acute Myeloid Leukemia Treatment Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Acute Myeloid Leukemia Treatment Revenue Market Share by Countries in 2019
Figure 43. China Acute Myeloid Leukemia Treatment Revenue and Growth Rate (2015-2020)
Figure 44. Japan Acute Myeloid Leukemia Treatment Revenue and Growth Rate (2015-2020)
Figure 45. Korea Acute Myeloid Leukemia Treatment Revenue and Growth Rate (2015-2020)
Figure 46. India Acute Myeloid Leukemia Treatment Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Acute Myeloid Leukemia Treatment Revenue and Growth Rate (2015-2020)
Figure 48. South America Acute Myeloid Leukemia Treatment Revenue Market Share by Countries (2015-2020)
Figure 49. South America Acute Myeloid Leukemia Treatment Revenue Market Share by Countries in 2019
Figure 50. Brazil Acute Myeloid Leukemia Treatment Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Acute Myeloid Leukemia Treatment Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Acute Myeloid Leukemia Treatment Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Acute Myeloid Leukemia Treatment Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Acute Myeloid Leukemia Treatment Revenue and Growth Rate (2015-2020)
Figure 55. UAE Acute Myeloid Leukemia Treatment Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Acute Myeloid Leukemia Treatment Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Acute Myeloid Leukemia Treatment Revenue and Growth Rate (2015-2020)
Figure 58. Global Acute Myeloid Leukemia Treatment Revenue Share by Type (2015-2020)
Figure 59. Global Acute Myeloid Leukemia Treatment Revenue Share by Type in 2019
Figure 60. Global Acute Myeloid Leukemia Treatment Market Share Forecast by Type (2021-2025)
Figure 61. Global DC regimen Revenue Growth Rate (2015-2020)
Figure 62. Global AVD Regimen Revenue Growth Rate (2015-2020)
Figure 63. Global VCD regimen Revenue Growth Rate (2015-2020)
Figure 64. Global Acute Myeloid Leukemia Treatment Revenue Share by Application (2015-2020)
Figure 65. Global Acute Myeloid Leukemia Treatment Revenue Share by Application in 2019
Figure 66. Global Acute Myeloid Leukemia Treatment Market Share Forecast by Application (2021-2025)
Figure 67. Global Hospital Revenue Growth Rate (2015-2020)
Figure 68. Global Clinic Revenue Growth Rate (2015-2020)
Figure 69. Global Others Revenue Growth Rate (2015-2020)
Figure 70. Global Acute Myeloid Leukemia Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Acute Myeloid Leukemia Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Acute Myeloid Leukemia Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Acute Myeloid Leukemia Treatment Revenue Market Forecast (2021-2025)
Figure 74. Europe Acute Myeloid Leukemia Treatment Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Acute Myeloid Leukemia Treatment Revenue Market Forecast (2021-2025)
Figure 76. South America Acute Myeloid Leukemia Treatment Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Acute Myeloid Leukemia Treatment Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel

---